Skip to main content

Table 3 MiR-182-5p expression in LUAD from miRNA-seq data

From: MiR-182-5p and its target HOXA9 in non-small cell lung cancer: a clinical and in-silico exploration with the combination of RT-qPCR, miRNA-seq and miRNA-chip

CharacteristicsnRelevant expression of miR-182-5p (log2x)
Mean ± SDt/F-valueP-value
TissueLUAD44814.273 ± 0.94717.368< 0.001*
Noncancerous4511.644 ± 1.160
GenderMale20914.259 ± 0.902−0.3060.760
Female23914.286 ± 0.987
Age(years)≤503314.295 ± 1.2050.1750.862
> 5039614.257 ± 0.932
TT1 + T238814.294 ± 0.9540.6790.497
T3 + T45714.203 ± 0.871
NodesNo29314.252 ± 0.966−1.0250.306
Yes14614.349 ± 0.892
MetastasisNo28514.326 ± 0.898−0.3660.715
Yes1914.404 ± 1.027
Pathologic stageI-II35114.249 ± 0.958−0.8100.419
III-IV9214.340 ± 0.918
Anatomic neoplasm subdivisionL-Lower7014.229 ± 0.8250.512a0.727
L-Upper10814.206 ± 0.998
R-Lower8514.214 ± 0.940
R-Middle1814.281 ± 0.789
R-Uppr15514.351 ± 0.986
Tumor locationPeripheral11314.309 ± 0.940−0.7430.459
Central5414.429 ± 1.051
  1. LUAD: lung adenocarcinoma; SD: standard deviation
  2. a One-way analysis of variance (ANOVA) was performed
  3. * The results were statistically significant (P < 0.05)